NCT05440513 - A Study of Non-Vascular Renal Denervation Using the Verve Medical Phoenix ™ System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

February 5, 2022

Study Completion Date

December 15, 2022

Conditions

HypertensionUncontrolled Hypertension

Interventions

DEVICE

Renal Pelvic Denervation (bilateral)

Using the natural orifice of the urethra, the ureters are accessed (bilaterally and in sequence), to allow for an ablation device to be placed into the renal pelvis where RF energy is delivered to ablate renal nerves.

Trial Locations (2)

Unknown

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

Pineo Medical Ecosystem, Tbilisi